Kim Thompson, Ryan Masotti, Kenneth Carter, Deepa Das Acevedo, Gerard Vong, Michael Winkler
Collaboration between physician Key Opinion Leaders (KOLs) and the health care industry accelerates the adoption of new therapies, but public awareness of industry payments and research linking such payments to prescribing behaviors has fueled a sharp decline in trust. Meanwhile, for-profit, industry-aligned credentialing programs have begun to define and train KOLs with little public accountability. Without independent alternatives, these models may entrench standards that serve corporate interests over the public good. We review the evolution of the KOL role, from early communication theory to its integration into pharmaceutical marketing and examine the rise of Public Scholarship (PS) as an academic movement grounded in beneficence, transparency, and civic accountability. From this analysis, we propose a Key Opinion Leader Public Scholarship Certification (KOL-PSC) program, governed jointly by academics and patient advocates, to align KOL influence with public interests. The KOL-PSC model includes a skills-based curriculum in ethical science communication, patient engagement, and conflict-of-interest management, culminating in a public-facing capstone project. Governance safeguards will ensure independence from commercial influence while offering industry the reputational benefits of working with certified experts. This voluntary, non-regulatory credential offers a proactive means to restore public trust in physician-industry collaboration, thereby benefitting patients, physicians, academia, and industry.